Please note: The Health 4.0 accelerator program is no longer running, as it has been superseded by the new DayOne Accelerator. Click the button to learn about our new flagship program.
Propelling digital health scale-ups in pharma
DayOne Health 4.0 was our previous six-month hybrid accelerator program in the Basel Area, Europe’s healthcare hub. We supported startups innovating across the healthcare spectrum, from diagnosis to prevention, patient and caregiver communication and support for healthcare professionals.
Our last edition of this program, running from September 2024 to March 2025, focused on Artificial Intelligence, data and digitally enhanced clinical development.
How the program worked
Phase 1 (3months):
It was all about ‘Pharma 101’. We helped startups understand the pharma environment, plan how they would work with the industry and come up with their own unique value offering.
Phase 2 (3 months):
It was ‘Startup 101’. We turned our focus on the startups, nurturing their strengths and aligning their business model for meaningful collaborations with pharma companies.

No equity, no fee
Our goal was the startups’ success with pure dedication to scaling their digital health ventures.

2 phases, 1 goal
Discover pharma and shape themselves for successful collaboration.

Personalized coaching and mentoring
Find the best solutions for their venture with their personal coach and our advisors.

Direct access to our network
Gain access to our network of pharmaceutical and life sciences experts.

Innovation space
Work alongside entrepreneurs, coaches and industry experts at the Switzerland Innovation Park Basel Area.

Enhanced visibility
Showcase their startup at DayOne events and increase their visibility towards investors, partners and users.
Startup voices
Ruth Lotan
Briya
Maya Zlatanova
FindMeCure and TrialHub
Neeraj Apte
Avegen
Pedro Pereira
epHealth
Robert Lugowski
CliniNote
2022 Winners
Demo Day
Eligibility criteria
- Startup with a digital health solution
- Already have a product or an available (preferably patented) technology
- Have secured some funding (preferably Series A / pre-Series B stage)
- Have a product ready to launch or already launched in at least one market
- At least one founder can participate in the program and key events (e.g. interview with the selection committee, opening bootcamp, coaching and mentoring sessions, presentations to our partners)
Key dates
15 June 2024
Deadline to submit application
25 June 2024
Interview with the selection committee (online)
9-10 September 2024
Bootcamp to kick off phase 1 (Basel, in person)
31 March 2025
End of the accelerator program
2024 application themes
The main cohort theme was harnessing AI, data and digital tools to power clinical development with three key focus areas as below.
Harnessing AI, data and digital tools to power clinical development
Advancing clinical development
Harness data and clinical tools to improve endpoints
Reinventing clinical trials
Optimize patient identification, access and enrollment
Enhancing patient experience
Prioritize patient experience to boost outcomes
The transversal theme: simplifying operations
How the application process worked
Submit online application
Our 2024 edition core theme was about diving into the fascinating world of “AI, data and digitally enhanced clinical development”.
Await pre-selection
If the startup’s digital health solution fitted our criteria, they could have been pre-selected and invited to meet our committee.
Impress our committee
Pre-selected startups had the chance to meet our experts and pitch their solution in a 20 to 30-minute presentation. We chose 15 startups for our 2024 run.
Partners, advisors and ventures
Supporting partners
Previous Partners
Karin Sartorius
Innovation Manager Life Sciences, Kanton Basel-Stadt
Marlene Thomas
Comprehensive Genomic Profiling Strategy Lead, Roche
Janet Munro
Head Program Innovation, Global Drug Development, Novartis
Rado Andrian
Digital Health Strategy, Solutions, Innovation Programs & Partnerships expert, ex-Biogen
Francesc Calvo Serra
Digital Strategy Director, Novartis
Alexandra Charge
Global Head Healthcare BU Windmill and CEO, Nilaya
Ursula Costa
Healthcare Innovation Director, DayOne
Frank Desiere
Digital Health expert, Board Director & Chairman at Ivoclar
Ventsi Dobrev
Global Lead Digital Health, Ypsomed
Marlene Gyldmark
VP, Head Access Evidence, Idorsia
Alexander Klein
Group Leader Digital Health, Personalised Healthcare, Roche
Thierry Lavé
Head Roche R&D Academy, Roche
Enkelejda Miho
Professor of Digital Life Sciences, University of Applied Sciences and Arts Northwestern Switzerland
Francesco Patalano
Patient-focused drug development expert, ex-Novartis
Natasha Rostovtseva
Health tech and sustainability advisor, MD, ex-Google
Jasmin Saric
Innovative healthcare solutions expert, ex-BI
Caoimhe Vallely-Gilroy
- 18+ years in pharma, from clinical development to data strategy, digital health and digital therapeutics
- Startup advisor and board member
Caoimhe Vallely-Gilroy
Director Healthtech Strategy & Pharma
Shwen Gwee
- 20+ years driving digital strategy and Innovation in biopharma
- Specialized in technology adoption in hospital and medtech environments
- Startup co-founder
Shwen Gwee
Chief Representative USA – Healthtech
Alumni
